Literature DB >> 9105356

Management of hemangioma of infancy: review of 245 patients.

B M Achauer1, C J Chang, V M Vander Kam.   

Abstract

A retrospective study of patients treated from May of 1981 to April of 1994 was conducted. A total of 245 patients with 299 hemangiomas were studied, which represents the largest series reported to date. The study consisted of 173 females and 72 males ranging in age from 1 day to 59 years, with the average age being 4 years and 7 months. Twenty-six were premature neonates (14 females and 12 males). An interesting finding was a 1:1 sex ratio among this group in contrast to the 3:1 female-male ratio frequently reported in the literature. Onset was at birth in 170, within the first month in 43, and after the age of 1 month in 32 patients. Among the 245 patients, 175 hemangiomas were located on the head and neck, 62 on the trunk, 49 on the extremities, and 13 in the perineal area. Five groups of patients were defined based on clinical management. As a result, these groups are not similar. The five groups are as follows: group I (48), observation; group II (9), steroid treatment; group III (27), excision and reconstruction; group IV (88), laser therapy; and group V (73), combined therapy. The involved area of hemangioma was as follows: group 1, 0.5 x 0.5 to 20 x 8 cm; group II, 2 x 2 to 8 x 8 cm; group III, 0.4 x 0.8 to 7 x 7 cm; group IV, 0.5 x 0.5 to 20 x 9 cm; and group V, 1.5 x 1.5 to 25 x 25 cm. The complications of hemangioma seen at the time of consultation were obstruction (28.6 percent), ulceration (20.4 percent), bleeding (14.7 percent), infection (4.9 percent), and pain (0.4 percent). Treatment periods ranged from 1 month to 11 years, with the mean period in each group as follows: group I, 4 years and 9 months; group II, 2 years and 5 months; group III, 1 year and 1 month; group IV, 2 years and 1 month; and group V, 3 years. The outcomes of each patient were evaluated based on improvement of volume, color, and texture by the following scale: 1, poor (0 to 25 percent); 2, fair (26 to 50 percent); 3, good (51 to 75 percent); and 4, excellent (76 to 100 percent). Each of these parameters was summarized for each of the five groups. Statistical analysis by the Irwin-Fisher test was used for analysis and comparison of the final results between groups. Statistically significant differences in outcomes between treatment groups were demonstrated. Laser therapy was shown to be statistically superior to observation with regard to length of treatment and with regard to outcomes of volume and texture (p < 0.05).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9105356     DOI: 10.1097/00006534-199704001-00014

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  29 in total

1.  Evaluating systemic prednisone therapy for proliferating haemangioma in infancy.

Authors:  Jochen Rössler; Goetz Wehl; Charlotte Marie Niemeyer
Journal:  Eur J Pediatr       Date:  2007-08-04       Impact factor: 3.183

2.  SACRAL syndrome.

Authors:  Devendra Kumar Yadav; Shasanka Shekhar Panda; Narinder Teckchandani; Deepak Bagga
Journal:  BMJ Case Rep       Date:  2013-07-31

3.  Efficacy and Safety of 2% Topical Propranolol Cream for the Treatment of Proliferating Infantile Strawberry Hemangiomas.

Authors:  Yuanyuan Wang; Xingcun Zhang; Yadong Yang; Junbo Zhang; Yunchuan Yang; Yuangang Lu
Journal:  Indian J Pediatr       Date:  2017-02-14       Impact factor: 1.967

4.  A survey on clinical use of propranolol for infantile hemangiomas in mainland China.

Authors:  Zheng-Gang Chen; Jia-Wei Zheng; Ling Zhang; Ling Zhu; Yan-An Wang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

5.  Embolization in the head and neck.

Authors:  Daniel Cooke; Basavaraj Ghodke; Sabareesh Kumar Natarajan; Danial Hallam
Journal:  Semin Intervent Radiol       Date:  2008-09       Impact factor: 1.513

6.  Effect of topical propranolol gel on plasma renin, angiotensin II and vascular endothelial growth factor in superficial infantile hemangiomas.

Authors:  Yu-Juan Tang; Zai-Zhong Zhang; Shao-Quan Chen; Shu-Ming Chen; Cheng-Jin Li; Jian-Wei Chen; Bo Yuan; Yin Xia; Lie Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

7.  Topical propranolol hydrochloride gel for superficial infantile hemangiomas.

Authors:  Lie Wang; Yin Xia; Yanan Zhai; Chengjin Li; Yiqing Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-12-28

8.  Clinical efficacy of propranolol in the treatment of hemangioma and changes in serum VEGF, bFGF and MMP-9.

Authors:  Shanying Wu; Biao Wang; Lifen Chen; Shuyuan Xiong; Fulian Zhuang; Xunlei Huang; Meishui Wang; Zugen Huang
Journal:  Exp Ther Med       Date:  2015-07-20       Impact factor: 2.447

Review 9.  [Innovations in dermatologic laser therapy].

Authors:  U Hohenleutner
Journal:  Hautarzt       Date:  2010-05       Impact factor: 0.751

10.  Preliminary experience on treatment of infantile hemangioma with low-dose propranolol in China.

Authors:  Xiaorong Ma; Tinghui Zhao; Yan Xiao; Jie Yu; Huiping Chen; Yinying Huang; Jun Liu; Jun Lin; Tianxiang Ouyang
Journal:  Eur J Pediatr       Date:  2013-01-23       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.